Acnevulgaris
Acnevulgaris
Acnevulgaris
2
What is Acne?
Acne vulgaris is a chronic, inflammatory disease of the
pilosebaceous units of the skin.
Pilosebaceous unit
= hair + hair follicle + sebaceous gland
Sebaceous gland
Found in hair-covered areas
Functions to secrete sebum, an oily substance that acts to protect and
waterproof skin and hair, and keep it from being dry, brittle, and
cracked
3
Epidemiology
Age
Acne can present at any point during a person’s life
Adolescent acne usually presents prior to the onset of
puberty
Sex
During adolescence, acne is more common in males than
females
During adulthood, acne is more common in females than
males
4
Epidemiology cont…
US population
Acne affects more than 85% of teenagers
Results in more than 2 million visits to the doctor per year for patients
15-19 years of age
Mean age at presentation for treatment is 24 years
10% of doctor’s visits take place when patients are between the ages of 35
and 44 years.
Financial impact
Direct cost of acne in the US is estimated to exceed $1 billion per year
Of this amount, it is estimated that $100 million is spent on over-the-
counter acne products
5
Epidemiology cont…
Psychosocial impact
Social, psychological, and emotional impairment that can result from acne
has been reported to be similar to that associated with other chronic
medical conditions like arthritis, asthma, diabetes, and epilepsy
Scarring associated with acne can lead to lifelong problems with regards
to self-esteem
6
The Skin
7
Pathophysiology
Primary Causes
Increased sebum production
Abnormal epithelial desquamation
Bacterial growth
Inflammation
Secondary Triggers
Mechanical obstruction (e.g., helmets, shirt collars)
Increased hormonal activity (e.g., menstrual cycles, puberty)
Stress (due to increased output of hormones from the adrenal gland)
Cosmetics and emollients (occlude follicles and cause an acneiform eruption)
Medications with halogens (iodine, chlorine, bromine)
Lithium, barbiturates, androgens
Anabolic steroids
8
1. Increased Sebum Production
9
2. Abnormal Epithelial Desquamation
10
3. Bacterial Growth
11
4. Inflammation
12
Clinical Presentation
Acne may present on the face, neck, chest, back,
shoulders, or upper arms
13
Type of Lesion
Non-Inflammatory
Comedonal
“Whitehead” – dilated hair follicle filled with keratin, sebum, and bacteria,
with an obstructed opening to the skin
“Blackhead” – dilated hair follicle filled with keratin, sebum, and bacteria,
with a wide opening to the skin capped with a blackened mass of skin debris
Inflammatory
Papulo-pustular
Papule – small bumps less than 5mm in diameter
Pustule – small bump with a visible central core of purulent material
Nodulocystic
Nodule – bump greater than 5mm in diameter
14
Severity
15
Mild Acne
16
Moderate Acne
17
Moderately Severe
18
Severe Acne
19
Diagnosis
20
Therapeutic Objectives
21
Treatment Options
Non-pharmacologic
Surface skin cleansing
Pharmacologic
Topical products
Oral antibiotics
Isotretinoin
Hormonal agents
22
Non-Pharmacologic Treatment
Surface skin cleansing with soap and water has a relatively small
effect on acne because it has minimal impact within follicle
23
Pharmacologic Treatment:
Topical Products
Benzoyl peroxide
Retinoid analogues
Topical antibiotics
Azelaic acid
24
Benzoyl Peroxide
Role in Acne Treatment:
Non-antibiotic antibacterial agent that is bacteriostatic against P. acnes
Increases the sloughing rate of epithelial cells and loosens the follicular plug structure
Proven effective in the treatment of acne
Availability
Available in a wide variety of dosage forms (e.g., soaps, lotions, creams, washes, and gels)
and dosages (e.g., 2.5% to 10%
Dosing
To limit irritation and increase tolerability, begin with lowest concentration and increase
either the strength or application frequency
Patients should apply the product to cool, clean, dry skin no more than twice daily
25
Retinoid Analogues
26
Retinoid Analogues cont…
Examples
Tretinoin (topical vitamin A acid)
Availability – wide variety of dosage forms and concentrations, including Retin-A-
Micro
Dosing – applied once nightly
Side Effects – skin irritation, erythema, peeling, increased sensitivity to sun exposure,
wind, or cold
Adapalene (Differin)
Availability – 0.1% gel, cream, alcoholic solution, and pledgets
Dosing - applied once daily at night or in the morning
Side Effects – minimal irritation
Tazarotene (Tazorac)
Availability – 0.05% and 0.1% gel or cream
Dosing – applied once nightly
Side Effects – irritation, erythema, burning, stinging
27
Topical Antibiotics
Role in Acne Treatment
Both erythromycin and clindamycin have demonstrated efficacy and are well
tolerated
Availability
Wide variety of dosage forms and concentrations
Also available in combination with benzoyl peroxide
Dosing
Erythromycin – applied once or twice daily
Clindamycin – applied once or twice daily
In combination with benzoyl peroxide – applied once or twice daily
28
Azaleic Acid
Role in Acne Treatment
Reported to possess comedolytic, anti-inflammatory, and antibacterial
properties
Availability
20% cream
Dosing
Applied twice daily on clean, dry skin
Side Effects
Mild transient burning, pruritus, stinging, and tingling
29
Pharmacologic Treatment:
Oral Antibiotics
Role in Acne Treatment
Standard of care in the management of moderate and severe acne as well as in
treatment-resistant forms of inflammatory acne
Examples
Minocycline – reserved for patients who do not respond to other oral antibiotics
or topical products; superior to doxycycline in reducing P. acnes
Doxycycline – more effective than tetracycline
Tetracycline – least expensive and most often prescribed for initial therapy
Erythromycin – effective, but use is limited to those who cannot use the
tetracyclines (e.g., pregnant women or children under 8 y.o.)
Trimethoprim-Sulfamethoxazole – effective, but use is limited to those who
cannot use the tetracyclines or erythromycin, or in case of resistance to these
antibiotics
Clindamycin – use is limited by diarrhea
30
Oral Antibiotics cont…
Dosing
Minocycline – 50-100mg once to twice daily
Doxycycline – 50-100mg once to twice daily
Tetracycline – 250-500mg twice to four times daily
Erythromycin – 250-500mg twice daily
Trimethoprim-Sulfamethoxazole – 160/800mg twice daily
Clindamycin – use is limited by diarrhea
31
Pharmacologic Treatment:
Isotretinoin
Role in Acne Treatment
Indicated for severe nodular or inflammatory acne in patients unresponsive to
conventional therapies, for scarring, for those with chronic relapsing acne, and for
acne associated with severe psychological distress
Decreases sebum production, changes in sebum composition, inhibits P.acnes
growth within follicles, inhibits inflammation
iPLEDGE
This agent is a potent teratogen, and thus should only be prescribed by physicians
knowledgeable in its appropriate administration and monitoring
Female patients of child-bearing potential must only be treated with this agent if
they are participating in iPLEDGE, the approved pregnancy prevention and
management program
Physician enters the patient’s information into the iPLEDGE website
Dispensing pharmacist interviews patient and verifies patient information on
website
Patient has to sign a consent form to comply with the program
32
Isotretinoin cont…
Dosing
0.5-2.0mg/kg/day
Drug is usually given for a 20 week course of therapy
Lower doses can be used for a longer time period, with a total cumulative
dose of 120-150mg/kg
33
Pharmacologic Treatment:
Hormonal Agents
Role in Acne Treatment
Estrogen-containing oral contraceptives can be useful in the treatment of
acne in some women
34
References
American Academy of Dermatology: Guidelines of Care for Acne Vulgaris
Management. Access on 11/26/2006 at
http://www.aad.org/professionals/guidelines/guidelines.htm.
James WD. Clinical Practice: Acne. N Engl J Med. 2005 Apr 7;352(14):1463-72.
Feldman S, Careccia RE, Barham KL, Hancox J. Diagnosis and treatment of acne. Am
Fam Physician. 2004 May 1;69(9):2123-30.
Bershad SV. The modern age of acne therapy: a review of current treatment options.
Mt. Sinai J Med. 2001 Sept-Oct;68(4-5):279-86.
Federman DG, Kirsner RS. Acne vulgaris: pathogenesis and therapeutic approach. Am
J Manag Care. 2000 Jan;6(1):78-87.
35